Indefinite Delivery Contract 75D30120D07982
Award Date
4/23/20
Last Date to Order
4/22/21
Federal Agency
CDC Pittsburgh
Awardee
Corgenix Medical Corporation
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide serology surge testing services. The contract has a ceiling value of $23,750,000 and a period of performance from April 2020 to April 2021. As a multiple award IDC, this vehicle provides the CDC with flexible access to Battelle's scientific and technical capabilities in areas...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021. Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its...
The Indefinite Delivery Contract is a multiple award issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. It has a potential value of $23,750,000 and was awarded on April 23, 2020 to the University of Washington School of Medicine for SURGE SEROLOGY TESTING. No set-aside was used. Orders may be placed through April 22, 2021. The purpose of the contract is to provide surge serology testing in support of the Centers for Disease Control and...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Bioreference Health LLC for surge serology testing in support of COVID-19 response efforts. The potential value of the contract vehicle is $23.75 million. Under the contract, Bioreference Health will perform testing services out of its laboratory in Elmwood Park, New Jersey. A $1.85 million firm fixed price delivery order was issued to Bioreference Health to conduct testing from July 30,...
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Massgenics Inc., a division of Innova Solutions, Inc., with a potential value of $45 million. The contract provides for international technical, operational, and professional support services under the ITOPSS 4.0 program. A cost-plus-fixed-fee delivery order was also issued against this contract for $25,000 to support such services in Angola. The base period of performance for both the contract and first...
This Indefinite Delivery Contract is a multiple award IDIQ awarded by the Centers for Disease Control and Prevention (CDC) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston, Massachusetts. The $118 million contract, with an ultimate completion date of September 5, 2029, is for "Test Surge and Data Sharing" services. Under this IDIQ, Ginkgo Bioworks is expected to provide testing and data sharing capabilities to support the CDC's public health monitoring and emergency...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) with the Centers for Disease Control and Prevention (CDC) for $24.9 million. The contract was awarded on September 20, 2024 to Goldbelt Professional Services, LLC, an Alaskan Native Corporation-owned firm and SBA-certified 8(a) Program participant. The IDC provides the CDC's National Center for Immunization and Respiratory Diseases with a wide range of scientific, professional, and technical support services....
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Ami Expeditionary Healthcare, LLC, a for-profit limited liability company. The single-award IDV has a ceiling value of $25,001,500 and is for the provision of commercial COVID-19 emergency response teams to support the CDC's pandemic response efforts. Under the IDV, the CDC has issued multiple time-and-materials and firm-fixed-price delivery orders to Ami Expeditionary Healthcare for services...